Compare PG & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PG | TMO |
|---|---|---|
| Founded | 1837 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.2B | 164.3B |
| IPO Year | 2014 | 1996 |
| Metric | PG | TMO |
|---|---|---|
| Price | $148.96 | $510.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 18 |
| Target Price | $163.64 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 7.1M | 2.1M |
| Earning Date | 04-24-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.89% | 0.40% |
| EPS Growth | ★ 8.14 | 7.32 |
| EPS | ★ 5.36 | 4.43 |
| Revenue | ★ $84,284,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | $5.76 | $6.55 |
| Revenue Next Year | $2.57 | $5.11 |
| P/E Ratio | ★ $27.72 | $114.24 |
| Revenue Growth | 0.29 | ★ 14.47 |
| 52 Week Low | $137.62 | $401.45 |
| 52 Week High | $166.90 | $643.99 |
| Indicator | PG | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 65.37 |
| Support Level | $139.09 | $457.06 |
| Resistance Level | $152.77 | $520.66 |
| Average True Range (ATR) | 2.67 | 13.50 |
| MACD | 0.15 | 3.87 |
| Stochastic Oscillator | 60.66 | 91.07 |
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).